Improvement of RNA Aptamer Activity against Myasthenic Autoantibodies by Extended Sequence Selection
- 18 January 2002
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 290 (2), 656-662
- https://doi.org/10.1006/bbrc.2001.6252
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Potent 2′-amino-, and 2′-fluoro-2′- deoxyribonucleotide RNA inhibitors of keratinocyte growth factorNature Biotechnology, 1997
- Isolation of a nuclease-resistant decoy RNA that can protect human acetylcholine receptors from myasthenic antibodiesNature Biotechnology, 1997
- Isolation of a nuclease-resistant decoy RNA that selectively blocks autoantibody binding to insulin receptors on human lymphocytes.The Journal of Experimental Medicine, 1996
- DIVERSITY OF OLIGONUCLEOTIDE FUNCTIONSAnnual Review of Biochemistry, 1995
- Myasthenia GravisThe New England Journal of Medicine, 1994
- Bacterial expression of a single‐chain Fv fragment which efficiently protects the acetylcholine receptor against antigenic modulation caused by myasthenic antibodiesEuropean Journal of Immunology, 1993
- Kinetic Characterization of Ribonuclease-Resistant 2′-Modified Hammerhead RibozymesScience, 1991
- In vitro selection of RNA molecules that bind specific ligandsNature, 1990
- Systematic Evolution of Ligands by Exponential Enrichment: RNA Ligands to Bacteriophage T4 DNA PolymeraseScience, 1990
- Antibody Heterogeneity and Specificity in Myasthenia GravisaAnnals of the New York Academy of Sciences, 1987